ATE135468T1 - Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen - Google Patents

Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen

Info

Publication number
ATE135468T1
ATE135468T1 AT92902434T AT92902434T ATE135468T1 AT E135468 T1 ATE135468 T1 AT E135468T1 AT 92902434 T AT92902434 T AT 92902434T AT 92902434 T AT92902434 T AT 92902434T AT E135468 T1 ATE135468 T1 AT E135468T1
Authority
AT
Austria
Prior art keywords
prostate cancer
specific antigen
testing
prostatic specific
serum prostatic
Prior art date
Application number
AT92902434T
Other languages
English (en)
Inventor
Fernand Labrie
Original Assignee
Endorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24570513&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE135468(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Endorecherche Inc filed Critical Endorecherche Inc
Application granted granted Critical
Publication of ATE135468T1 publication Critical patent/ATE135468T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92902434T 1991-01-14 1992-01-13 Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen ATE135468T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64099691A 1991-01-14 1991-01-14

Publications (1)

Publication Number Publication Date
ATE135468T1 true ATE135468T1 (de) 1996-03-15

Family

ID=24570513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902434T ATE135468T1 (de) 1991-01-14 1992-01-13 Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen

Country Status (13)

Country Link
EP (1) EP0579607B1 (de)
JP (1) JPH06507236A (de)
AT (1) ATE135468T1 (de)
AU (1) AU666643B2 (de)
CA (1) CA2100464C (de)
DE (1) DE69209063T2 (de)
ES (1) ES2086725T3 (de)
IE (1) IE70072B1 (de)
IL (1) IL100527A (de)
MY (1) MY110321A (de)
NZ (1) NZ241199A (de)
WO (1) WO1992012430A1 (de)
ZA (1) ZA92264B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123151T1 (de) * 1992-10-21 1995-06-15 Edith Dr Dr Huland Verfahren zur quantitativen bestimmung von krankheitsspezifischen antigenen und vorrichtung zur durchführung des verfahrens.
FR2703788B1 (fr) * 1993-04-09 1996-12-20 Jacques Toledano Dispositif et procede anti-idiotype de detection immunologique.
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
CA2229427A1 (en) * 1995-09-12 1997-03-20 The General Hospital Corporation Method for early detection of ovarian cancer
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
AU7130696A (en) * 1995-09-19 1997-04-09 Schering Aktiengesellschaft Combination of beta-interferon for the treatment of prostate cancer
WO2000049158A2 (en) * 1999-02-18 2000-08-24 Compugen Ltd. Psa and klk-2 splicing variants
CN116242787B (zh) * 2023-03-07 2025-06-17 厦门大学 一种前列腺癌高特异性光谱检测方法与癌症判断装置

Also Published As

Publication number Publication date
MY110321A (en) 1998-04-30
ZA92264B (en) 1993-07-14
ES2086725T3 (es) 1996-07-01
AU666643B2 (en) 1996-02-22
IL100527A0 (en) 1992-09-06
NZ241199A (en) 1994-06-27
WO1992012430A1 (en) 1992-07-23
DE69209063T2 (de) 1996-10-02
CA2100464A1 (en) 1992-07-15
IE70072B1 (en) 1996-10-30
EP0579607A1 (de) 1994-01-26
CA2100464C (en) 2002-10-08
DE69209063D1 (de) 1996-04-18
EP0579607B1 (de) 1996-03-13
IE920093A1 (en) 1992-07-15
IL100527A (en) 1997-06-10
JPH06507236A (ja) 1994-08-11
AU1156792A (en) 1992-08-17

Similar Documents

Publication Publication Date Title
DE69929185D1 (de) Tumormarker
FI891078A0 (fi) Peptider och antikroppar, som inhiberar plateletadhesion.
DE68901632D1 (de) Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen.
DE3688612D1 (de) System mit elektronenstrahlpruefsonde zum analysieren integrierter schaltungen.
DK455384D0 (da) Middel og produkt til diagnose og terapi af tumorer samt til behandlingen af svaekkelser af celle- og humoral-immunforsvar
IL109817A0 (en) Improved method and analytical system for performing fibrinogen assays accurately, rapidly and simply
NO160746C (no) Fremgangsmaate for paavisning av okkult blod i fecesproever.
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
DE69729156D1 (de) Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA)
NO953770L (no) Analysemetode
NO161287C (no) Homogen immunologisk analysemetode, reagensmidler og proeveinnretning for bruk ved immunoanalysebestemmelse.
DK0673390T3 (da) Deltalignende gen, som udtrykkes i neuroendokrine tumorer
ATE135468T1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
SE8802737D0 (sv) Forfarande och apparat for metning av ett avstand medelst ultraljudimpulser
DE69719737D1 (de) Immunoassay von vollblutproben
ATE214161T1 (de) Verfahren zur diagnose adenokarzinom oder benigne pathologie der vorsteherdrüse
EA199900775A1 (ru) Быстрый способ диагностики рака
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
WO1998046993A3 (en) Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor
NO861554L (no) Anti-urokinasemonoklonalt antistoff, matrise inneholdende dette, testmetode og biokjemisk testutstyr som anvender det.
ES2045252T3 (es) Procedimiento y reactivo para la determinacion de hierro.
DK0519536T3 (da) Diagnostisk fremgangsmåde
ES548488A0 (es) Metodo para la cuantificacion del antigeno procoagulante delcancer en una muestra biologica
BE900911A (fr) Procede de diagnostic d'infections.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked